AzTrials
AzTrials

Lower Leg AmputationsProMobNCT04904003

Prosthetic Use, Mobility and Daily Functioning

A study testing Rehabilitation Intervention in people with Lower Leg Amputations, run by Oslo Metropolitan University at 2 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of the project is to explore which elements of rehabilitation that influence mobility in new and experienced unilateral lower-limb amputees. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lower Leg Amputations
What is being tested?
Rehabilitation Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesNorway
Study dates
9 Apr 2021to 15 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilaterally amputated (above the ankle joint / under the hip joint)
  • No prior record of use of prosthesis
  • Participation approved by physician

Who cannot join

  • Bilaterally amputated over ankle joint
  • Lack of understanding of Norwegian language (oral, written)
  • Neurological disorders affecting gait function
  • Skin lesion or abrasion on the stump or remaining extremity affecting mobility and function
  • Other issues that complicate participation in a rehabilitation intervention

Trial locations and contacts

2 sites in 1 country.

Norway2 sites
  • Unicare Bakke

    Halden, Akershus, 1765

  • OsloMet

    Oslo, 0130

Other trials in Norway

About this study

The goal of the project is to explore which elements of rehabilitation that influence mobility in new and experienced unilateral lower-limb amputees.

Read the detailed description

Both new and experienced unilateral lower limb amputees (LLA) describe difficulties when ambulating intentionally and independently from one place to another using prosthesis. In LLA, this decreased ability to mobilize affect daily functioning and may result in low activity-levels, impeded social participation and reduced health-related quality of life.

Both primary and secondary rehabilitation of LLA have implications for functional mobility. The consensus among health professionals is that LLA should train to improve their ability to ambulate. However, knowledge from research regarding which elements that constitute effective training and how systematic exercise affects body structures, functions, activity and participation in lower limb amputees, is limited.

There also is a lack of knowledge of how prosthetic users endure and process the challenges regarding mobility, how they adapt to the use of their prosthesis, how safe they are ambulating using the prosthesis, and how pain and psychosocial issues affect their perceived health and mobility.

The aim of this Ph.D.-project is to explore how a period of semi-standardized individualized rehabilitation originating from an evidence-based approach, affect the functional mobility of both new and experienced LLA, and how LLA process the loss of a limb and challenges during ambulation.

Being tested
Rehabilitation Intervention
Keywords
Rehabilitation, Prosthetic mobility, Outcome measures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rehabilitation InterventionOther

    Strength, flexibility, endurance, balance, mobility, (self-efficacy)

Study groups in NCT04904003
Study groupRoleWhat they receive
Experienced LLA - interventionExperimentalExperienced lower-limb amputees that complete a 4-week semi-structured individualized rehabilitation regime with extensive testing before and after the intervention.
Receives: Other: Rehabilitation Intervention
Experienced LLA - controlsExperimentalExperienced lower-limb amputees that will be tested with a 4-week interval. No intervention. This group will be matched to the group of experienced lower-limb amputees.
Receives: Other: Rehabilitation Intervention
New LLA learning to use prosthesisExperimentalNew lower-limb amputees that complete a 8-11 weeks semi-structured individualized rehabilitation regime with extensive testing before and after the intervention.
Receives: Other: Rehabilitation Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prosthetic Limb Users Survey of Mobility (Plus-M) Short form - 12 items

    A questionnaire that measures different aspects of mobility in lower-limb amputees (LLA) using prosthesis. PLUS-M provide a score range from 17.5 to 76.6. High scores indicate better outcome.

    Measured: 4-8 weeks

  2. The Amputee Mobility Predictor (AMP).

    The test is designed to measure mobility and ability to move with prosthesis (AMPPro) and without prosthesis (AMPNoPro). AMPPro provide a score range from 0-47. AMPNoPro provide a score range from 0-43. High scores indicate better outcome.

    Measured: 4-8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2021
  2. Study start9 Apr 2021
  3. Primary completion15 Jun 2022
  4. Study completion15 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
One explorative group, one intervention group and one control group
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04904003
Sponsor's protocol ID
2018/2577
Acronym
ProMob
Status last verified
Jun 2022
First submitted
5 May 2021
Last updated
12 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is not a plan to make IPD available. The GDPR-regulations make sharing of research data both time-consuming and difficult.

Questions about this trial

What is this clinical trial studying?

A study testing Rehabilitation Intervention in people with Lower Leg Amputations, run by Oslo Metropolitan University at 2 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prosthetic Limb Users Survey of Mobility (Plus-M) Short form - 12 items (time frame: 4-8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in